Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

224 | REGULAR ASPIRIN USE PRIOR TO DIAGNOSIS AND FOLLICULAR LYMPHOMA PROGNOSIS: NOVEL ASSOCIATION WITH SUPERIOR EVENT‐FREE SURVIVAL
Cholack, George , Mwangi, Raphael , Bisneto, J. V., Robinson, Don, Witzig, T. E., Ansell, Steven M., Novak, Anne J. , Thompson, Carrie A. , Nowakowski, G. S., Wang, Y., Cholack, George A , Bisneto, J. V., Habermann, Thomas M. , Feldman, Andrew L. , Mou, Eric , Slager, Susan L. , Maurer, Matthew J. , Wang, Yucai , Cerhan, James R.

Mayo Clinic

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70094_224 Get It

324 | RAPID RAMP‐UP DOSING OF BI‐SPECIFIC ANTIBODIES IN RELAPSED OR REFRACTORY LARGE B‐CELL LYMPHOMA
Wang, Y., Nedved, Adrienne, Fahmawi, Suhib, Lutfi, Forat , Johnson, Paul C., Dong, Ning , Hill, Brian T. , Nowakowski, G., Larson, Melissa C. , Wang, Jun , Karmali, Reem , Lei, Matthew , Johnson, P. C., Moustafa, Muhamad Alhaj , Chavez, Julio C , Brooks, Taylor , Muñoz, Javier , Hu, Yifei , Riedell, Peter A. , Godbole, S., Sawalha, Yazeed , Rhodes, Joanna

Mayo Clinic

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70094_324 Get It

557 | EVALUATING UPTAKE OF TARGETED AGENTS BY RACE/ETHNICITY IN PATIENTS RECEIVING FIRST‐LINE TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA
Kittai, Adam S. , Hampel, Paul J. , Fu, Qiang , Sun, Steven , Beuge, Derrick van, Maglinte, Gregory A. , Rhodes, Joanna , Wang, X., Seymour, Erlene Kuizon , Barrientos, Jacqueline C.

Mayo Clinic

Hematological Oncology | June 15, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70096_557 Get It

572 | PATIENT‐REPORTED OUTCOMES IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA PATIENTS TREATED WITH EPCORITAMAB: OVERALL AND SUBGROUP ANALYSIS BY BASELINE SYMPTOM BURDEN
Johnson, P. C., Nsiah, Irene , Ding, Zhijie , Mutebi, Alex , Patah, Poliana, Favaro, Enrico, Dueck, Amylou C. , Ghione, Paola , Major, Ajay , Wang, Anthony , Alshreef, Abualbishr , Yu, Jovian , Favaro, E., Jurczak, Wojciech

Mayo Clinic

Hematological Oncology | June 15, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70096_572 Get It

Knowledge Self-Assessment Engagement and Family Medicine Board Examination Outcomes
Wingrove, Peter , Bazemore, Andrew , Wang, Ting , Stelter, Keith, Price, David W. , Stelter, Keith

Mayo Clinic

Family Medicine | June 13, 2025 | Volume: 57 | Issue: 7 | Pages: 500-507

10.22454/fammed.2025.200510 | PMID 40526852 Get It

Background and Objectives: Evidence on the relationship between formative assessment engagement and summative assessment outcomes in practicing physicians is sparse. We evaluated the relationship between engagement in the American Board of Family Medicine (ABFM) formative Continuous Knowledge Self-Assessment (CKSA) and performance on high-stakes summative assessments. Methods: This retrospective cohort study included 24,926 ABFM diplomates who completed CKSA modules and summative assessments between 2017 and 2023. We analyzed CKSA engagement metrics—such as the number of quarters completed, time of completion, and self-reported confidence—against performance on summative assessments, measured by z scores. Multivariable regression models controlled for demographic factors and prior assessment performance. Results: The overall cohort summative assessment pass rate during the study period was 90.3%. Greater CKSA engagement was strongly associated with higher summative assessment performance. Diplomates who completed all four CKSA quarters had significantly higher summative assessment z scores than those completing fewer quarters (P<.001). Early CKSA completion and spending more time on low-confidence questions were also positively correlated with both CKSA and summative assessment scores (P<.001). These effects were observed across different levels of prior exam performance. Conclusions: Engagement in formative assessments like CKSA, particularly early and consistent participation and reviewing incorrect or low-confidence questions, is linked to better outcomes on high-stakes assessments. Future research should explore the mechanisms underlying these associations and consider developing an index of engagement to identify physicians at risk of poor performance. Incorporating structured, longitudinal self-assessments like CKSA into certification requirements could enhance continuous learning and improve summative exam readiness.
Guide to the diagnosis of lymphoid neoplasms in blood and bone marrow: A Bone Marrow Pathology Group approach
Foucar, Kathryn , Bagg, Adam , Bueso‐Ramos, Carlos E., Geyer, Julia T. , Hasserjian, Robert P. , Reichard, Kaaren K. , Tam, Wayne , Wang, Sa A. , Weinberg, Olga K. , Geyer, Julia T , Hsi, Eric D , Arber, Daniel A. , Bueso-Ramos, Carlos, Orazi, Attilio , Hsi, Eric D.

Mayo Clinic

American Journal of Clinical Pathology | June 10, 2025 | Volume: 164 | Issue: 5 | Pages: 650-693

10.1093/ajcp/aqaf068 | PMID 40994023 Get It

Abstract Objective The successful diagnosis and classification of lymphoid neoplasms in blood and bone marrow is the responsibility of the practicing pathologist. This guide provides a general “roadmap” for this process, from initial case recognition to final classification. Methods The integration of hematologic, morphologic, immunophenotypic, and genetic features for the full spectrum of precursor and mature B-cell, T-cell, and natural killer–cell neoplasms that typically manifest in blood and bone marrow is included. Results Classification systems for lymphoid neoplasms provide criteria for pathologists to render a diagnosis that is optimal for patient care, treatment, and outcome prediction. Conclusions This guide provides diagnostic strategies for lymphoid neoplasms encountered in blood and bone marrow specimens using both the International Consensus Classification and the World Health Organization fifth edition classification systems. Key tips are provided for each entity along with testing requirements, differential diagnosis, nonneoplastic mimics, and other unique features based on the experience of the Bone Marrow Pathology Group members.
Advances in intracerebral hemorrhage management: A comprehensive review
Wang, Jing , Elmadhoun, Omar, Zhao, Wenbo , Wang, Shengjun , Liang, Yong

Mayo Clinic

Brain Circulation | June 9, 2025 | Volume: 12 | Issue: 1 | Pages: 13-21

10.4103/bc.bc_177_24 | PMID 41815808 Get It

Intracerebral hemorrhage (ICH), caused by the rupture of small blood vessels, remains the least treatable subtype of stroke. The pathophysiology of ICH involves immediate mechanical compression from the hematoma, followed by secondary injuries such as cerebral edema, inflammation, and neuronal damage. Management aims to prevent hematoma expansion, enable safe and effective hematoma evacuation, and mitigate secondary injuries. Recent advancements in clinical management, including blood pressure control, hemostatic therapy, surgical and minimally invasive hematoma removal, and complication management, offer new hope. This review synthesizes these advancements, integrating insights from recent research and clinical trials, and highlights significant progress in evidence-based approaches that pave the way for precise and personalized treatment strategies. Nonetheless, further research is necessary to enhance our understanding of ICH mechanisms and develop more effective clinical interventions.
Concurrent Case of Glucose-6-Phosphate Deficiency and Dehydrated Hereditary Stomatocytosis in a 4-Month-old Boy
Sadiq, Sara, Peterson, Joshua M. , Wang, Leonard Kuan‐Pei , Botiralieva, Gulrukh , Chernov, Yaroslav, Muthukumar, Akila , Lyapichev, Kirill A , Nguyen, Thao Minh

Mayo Clinic

Journal of Pediatric Hematology/Oncology | June 6, 2025 | Volume: 47 | Issue: 6 | Pages: e278-e281

10.1097/mph.0000000000003057 | PMID 40479596 Get It

Glucose-6-phosphate (G6PD) deficiency is the most prevalent enzyme deficiency and is estimated to affect 400 million people. The patients are usually asymptomatic and diagnosed following hemolytic episodes triggered by oxidative stress. Another type of hemolytic anemia known as dehydrated hereditary stomatocytosis (DHSt) is estimated to affect less than 1 per 1,000,000 people. DHSt is caused by increased cation efflux and dehydration in red blood cells, which leads to decreased flexibility making them more vulnerable to lysis. Compared with G6PD, DHSt has a mild presentation, where most patients (84%) with isolated DHSt exhibit chronic hemolysis. Both diseases, G6PD deficiency and DHSt, are inherited hemolytic anemias and to the best of our knowledge have never been reported to coexist in the same patient. Herein, we present the first case of concurrent G6PD deficiency and DHS in a 4-month-old male. We discuss the clinical presentation and hematopathology findings from this patient as well as provide a comparison literature review. We believe this presentation will add to the current body of knowledge for these conditions and help to guide future investigation and management.